Patents by Inventor Glen Barber

Glen Barber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230288422
    Abstract: Disclosed herein is a method for enhancing antitumor T cell responses in subjects. The method involves administering to the subject in need thereof a composition comprising a demethylating agent in an amount effective to demethylate STING proteins in the tumor cells. This method is particularly useful in subjects with deficient STING expression in the tumor cells. Therefore, also disclosed is a method for treating a tumor in a subject that involves detecting in a biopsy sample from the subject reduced STING expression, reduced cGAS expression, or a combination thereof; and then administering to the subject a demethylating agent in an amount effective to demethylate STING proteins in the tumor cells. The method can further involve administering to the subject a therapeutically effective amount of a STING agonist. The method can further involve administering to the subject tumor infiltrating lymphocytes (TILs), such as HLA-matched TILs.
    Type: Application
    Filed: September 16, 2022
    Publication date: September 14, 2023
    Inventors: James Mulé, Rana Falahat, Glen Barber
  • Publication number: 20210161934
    Abstract: Disclosed herein is a method for enhancing antitumor T cell responses in subjects. The method involves administering to the subject in need thereof a composition comprising a demethylating agent in an amount effective to demethylate STING proteins in the tumor cells. This method is particularly useful in subjects with deficient STING expression in the tumor cells. Therefore, also disclosed is a method for treating a tumor in a subject that involves detecting in a biopsy sample from the subject reduced STING expression, reduced cGAS expression, or a combination thereof; and then administering to the subject a demethylating agent in an amount effective to demethylate STING proteins in the tumor cells. The method can further involve administering to the subject a therapeutically effective amount of a STING agonist. The method can further involve administering to the subject tumor infiltrating lymphocytes (TILs), such as HLA-matched TILs.
    Type: Application
    Filed: January 21, 2021
    Publication date: June 3, 2021
    Inventors: James Mulé, Rana Falahat, Glen Barber
  • Patent number: 9004051
    Abstract: An archery bow is comprised of at least a riser and two limbs that can be folded into a position forming its own case to protect the limbs, or taken down and reassembled with limbs of various draw weights. When taken down it may also be reconfigured to enable use by an archer with opposite handedness. In its folded state it is highly compact and transportable.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: April 14, 2015
    Inventor: Jeffrey Glen Barber
  • Publication number: 20150059720
    Abstract: An archery bow is comprised of at least a riser and two limbs that can be folded into a position forming its own case to protect the limbs, or taken down and reassembled with limbs of various draw weights. When taken down it may also be reconfigured to enable use by an archer with opposite handedness. In its folded state it is highly compact and transportable.
    Type: Application
    Filed: April 12, 2013
    Publication date: March 5, 2015
    Inventor: Jeffrey Glen Barber
  • Publication number: 20050244505
    Abstract: The present invention directs to compositions and methods for modulating immune system. One aspect of the present invention relates to a composition comprising FADD-dependent signaling pathway modulators. Another aspect of the present invention relates to biodegradable microparticles, such as a chitosan microparticle, or PLGA/PEI microparticle, designed to deliver nucleic acids and/or proteins, such as FADD-dependent signaling pathway modulators, to boost different pathways of an immune response. Another aspect of the present invention relates to the method of making biodegradable microparticles. The further aspect of the present invention relates to the use of the chitosan and other polycationic microparticles to deliver FADD-dependent signaling pathway modulators to modulate immune system for the prevention and/or treatment infectious diseases and cancers.
    Type: Application
    Filed: December 13, 2004
    Publication date: November 3, 2005
    Inventors: Russell Higbee, Glen Barber, Anatoly Kachurin, Olga Kachurina, Heather Gappa-Fahlekamp, William Warren, Siddharth Balachandran, Emmanuel Thomas, Robert Parkhill